pharmaceutical market Articles
-
A statistical examination of the integration of biotechnology in the Indian pharmaceutical sector
From the beginning of the 1970s a number of Indian pharmaceutical firms had invested in gaining technological competence without having "formal R&D centres"; and through efficient "reverse engineering" had slashed the prices of products otherwise sold by Western multinationals. However, their knowledge base was founded on the chemical technology of creating bulk drugs and ...
-
Tendering and decision–making: a case on pharmaceutical products
In order to contain expenditures for pharmaceuticals, the latest healthcare reforms have focused on decentralising German pharmaceutical market. Health insurance funds are now able to tender the products and subsequently conclude rebate contracts with one or more companies. Considering the enormous bargaining power of health insurance funds, pharmaceutical manufacturers, in particular companies ...
-
Commercialisation of bio-pharmaceutical therapies and risk management: the impact on the sustainability of markets for recombinant drugs
Due to its influence on changes of research paradigms and development of hitherto unknown applications, commercialisation of biotechnological knowledge causes new challenges for regulatory procedures in pharmaceutical markets. By affecting time and probability of successful commercialisation, private and public institutions systems of risk management also influence the structure of financing ...
-
Nurturing the stem cell business: lessons from the recombinant drugs markets?
The commercial use of embryonic or adult stem cells is still in its infancy. Most young firms concentrated on the generation and storage of stem cells, the development of tissues and related equipment. But the perspectives of therapeutic use of stem cells attract a lot of political and commercial attention to possible new strategic markets opening up new fields besides incumbent ...
-
Managing B2B relationships in the Croatian pharmaceutical industry
The main purpose of CRM is to get to know the customer as well as possible, which can help a company to deliver better, more appropriate and higher added value to the customer. A strong connection with the customers is the key to their satisfaction, especially if this connection is attained through recognising the customers' needs. This can become one of the crucial competitive advantages. Those ...
-
Conditions for the achievement of pharmaceutical innovation for sustainable development: lessons from India
This paper shows the post-TRIPS experience to be contradicting the overstated claim that "the adverse effect of TRIPS Agreement on prices of patented medicines would be adequately compensated by the benefits of technology transfer and domestic R&D". It argues that policymakers cannot continue to formulate their strategic interventions with an understanding that "strong IPRs are ...
-
The effects of globalisation on the pharmaceutical industry in emerging markets: the case of Turkey
Foreign Direct Investment (FDI) has become the most important determinant in the process of globalisation, and as such, it is changing the economies of many countries. The main objective of this research is to investigate the nature of FDI inflows into the Turkish pharmaceutical industry and examine whether local or multinational firms drive the changing market. The paper indicates that when ...
-
Genomics-based drug innovation: visions and commercial viability
This paper tracks the development of genomics between 1990 and 2005 principally within the US context and reviews that development with specific respect to early expectations of genomics-based pharmaceutical innovation, the initial claims made for it, and the realities of its current position. Emphasis is placed on relations between the genomics sector and its larger pharmaceutical and ...
-
Artificial Intelligence for New Drug Design
A Technology Platform for Deep-Learning-Based de novo Drug Design Digital tools are a key to shortening the development of active pharmaceutical ingredients and thus market-ready drugs and therapies. Big data and artificial intelligence (AI) can significantly accelerate many processes and make them more efficient. The Paris, Francebased start-up Iktos is developing a proprietary AI technology for ...
By Iktos
-
Drug Repurposing
Drug repurposing – uncovering new uses for already-approved medicines that could benefit patients facing a different need than originally intended – is bringing hope to millions of the desperately ill and their families. This is especially true for those suffering from rare diseases – who can’t wait a dozen or more years for a new treatment to be discovered, developed, ...
-
Artificial Intelligence for New Drug Design
Iktos Develops a Technology Platform for Deep Learning-Based de novo Drug Development Digital tools are a key to shortening the development of active pharmaceutical ingredients and thus market-ready drugs and therapies. Big data and artificial intelligence (AI) can significantly accelerate many processes and make them more efficient. The Paris, France-based start-up Iktos is developing a ...
By Iktos
-
Long–term value creation in the pharmaceutical sector: an event study analysis of big pharma stocks
We investigate the drivers of value creation in big pharmaceutical firms. We use a unique dataset of a total of 2,200 news items on research and development (R&D) progress announcements and dividend news of 25 largest pharmaceutical companies for the period 1998–2010. Our findings affirm the role of successful R&D as a driver of value creation in the long–run. This long term view of value ...
-
India Pharma Export 2021 Data Research And Facts
Despite the pandemic and global trade hurdles, Indian pharmaceutical companies continue to be a dominating player in the international pharmaceutical export market. India is the third-largest pharma exporter in the world. Supported by Pharmexil(Pharmaceutical Promotion Council of India), the Indian pharma industry recorded an increase of 18.7% in 2021, to rise to $24.4 Billion, the highest jump ...
-
Changing tides: Adaptive monitoring, assessment and management of pharmaceutical hazards in the environment through time
Pharmaceuticals are ubiquitous contaminants in aquatic ecosystems. Adaptive monitoring, assessment and management programs will be required to reduce the environmental hazards of pharmaceuticals of concern. Potentially underappreciated factors that drive the environmental dose of pharmaceuticals include regulatory approvals, marketing campaigns, pharmaceutical subsidies and re‐imbursement ...
-
Applications of Metagenomics in Biotechnology and Health Care
Microbes are present almost everywhere. They play a vital role in cycling carbon, release important compounds, and may be associated with infectious diseases. Metagenomics is the culture-independent genomic research of microbial communities. Metagenomics presents a powerful tool to study prokaryotes and viruses in the environment via the analysis of their DNA obtained directly from environmental ...
By CD Genomics
-
Applications of Metagenomics in Biotechnology and Health Care
Microbes are present almost everywhere. They play a vital role in cycling carbon, release important compounds, and may be associated with infectious diseases. Metagenomics is the culture-independent genomic research of microbial communities. Metagenomics presents a powerful tool to study prokaryotes and viruses in the environment via the analysis of their DNA obtained directly from environmental ...
By CD Genomics
-
A Team Approach to Translational Science
Success doesn’t just come from a winning idea or an exciting new concept. Success comes from having a dedicated team behind that idea, with the enthusiasm and commitment to drive it from concept to clinic. ...
-
Strategic alliance: case study in competitive positioning
The case seeks to identify some of the issues encountered in the development and growth of a family–owned firm in the pharmaceutical business in Lima, Peru. Having overcome the initial challenges of its establishment, the company has become a visible and viable competitor in the Peruvian market and is poised to expand in cross border markets by exploring the prospect of a strategic alliance with ...
-
Effective patent life in pharmaceuticals
Effective patent life is lost in pharmaceuticals because of the lengthy time periods required for clinical trials and regulatory approval. A 1984 US law restores some of this lost patent time, while also facilitating generic competition when patents expire. This paper examines this law and the effects of other policy developments on market exclusivity times in pharmaceuticals. It also performs ...
-
Rising to the technological challenge: possibilities for integration of biotechnology in the Indian pharmaceutical industry
Presently, the Indian pharmaceutical industry ranks 12th in the world and its market is conservatively estimated to be $2.5 billion. Tracing the evolution of this industry, the paper first shows that Indian firms over the years had invested in gaining knowledge of the chemical technology of creating bulk drugs, and the top tier firms had greatly "learnt by doing", improving upon the ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you